Editorial: Sudden cardiac death: mechanisms, risk and prevention
No abstractFront Cardiovasc Med. 2026 Sep 11;13:1983912. doi: 10.3389/fcvm.2026.1983912. eCollection 2026.NO ABSTRACTPMID:42798380 | PMC:PMC13612188 | DOI:10.3389/fcvm.2026.1983912
Effectiveness and safety of Breviscapine in the treatment of coronary heart disease: a meta-analysis of randomized controlled trials
Front Cardiovasc Med. 2026 Sep 11;13:1770569. doi: 10.3389/fcvm.2026.1770569. eCollection 2026.ABSTRACTBACKGROUND: Coronary heart disease is a leading cause of cardiovascular mortality. Residual angina pectoris often persists despite long-term treatment. Breviscapine, a plant-derived flavonoid, exhi
Astragaloside IV Attenuates Cardiac Aging Through Restoring Mitochondrial Dynamics Homeostasis by Promoting SIRT3-Mediated DRP1 Deacetylation
FASEB J. 2026 Oct 15;40(19):e72301. doi: 10.1096/fj.202504859R.ABSTRACTCardiac aging is a major risk factor for cardiovascular diseases, with an imbalance in mitochondrial dynamics homeostasis being a pivotal aspect. Although Astragaloside IV (AS-IV) has been shown to delay aging, its specific effec
Nurse practitioner impact across the cardiovascular care continuum: Insights from the American College of Cardiology Advanced Practice Nursing Workgroup
J Am Assoc Nurse Pract. 2026 Sep 25. doi: 10.1097/JXX.0000000000001369. Online ahead of print.ABSTRACTNurse Practitioners (NPs) are essential contributors to the contemporary cardiology workforce. The increasing prevalence of cardiovascular disease, coupled with persistent clinician shortages, has a
Vascular Disease Patient Information Page: Menopause and vascular health
No abstractVasc Med. 2026 Sep 25:1358863X261478097. doi: 10.1177/1358863X261478097. Online ahead of print.NO ABSTRACTPMID:42798145 | DOI:10.1177/1358863X261478097
Stress response physiology in the cardiac patient: from the laboratory to real life
Stress. 2026 Dec 31;29(1):2723352. doi: 10.1080/10253890.2026.2723352. Epub 2026 Sep 25.ABSTRACTRecognition of a "brain-heart axis" has grown substantially, highlighting the contribution of psychological stress on cardiovascular physiology and the development and progression of cardiovascular diseas
Predicting 90-day mortality in patients with HBV-ACLF: A comparison of machine learning models and logistic regression
Medicine (Baltimore). 2026 Sep 25;105(39):e50789. doi: 10.1097/MD.0000000000050789.ABSTRACTAcute-on-chronic liver failure (ACLF) is characterized by a high short-term mortality rate. Hepatitis B virus (HBV) infection is a major cause of ACLF in the Asia-Pacific region. This study aimed to compare th
Cardiomyopathy-related mortality in the United States, 1999 to 2023: A national population-based observational study
Medicine (Baltimore). 2026 Sep 25;105(39):e50903. doi: 10.1097/MD.0000000000050903.ABSTRACTCardiovascular disease remains a major global public health burden. In recent years, advances in cardiac imaging and molecular genetics have renewed clinical attention to the diagnosis, treatment, and preventi
Association of childhood loneliness with incident hypertension, heart disease, and stroke among low-educated Chinese women: A 9-year cohort study
Medicine (Baltimore). 2026 Sep 25;105(39):e50822. doi: 10.1097/MD.0000000000050822.ABSTRACTEarly-life psychosocial factors may be associated with long-term cardiovascular health. We investigated whether self-reported loneliness during childhood is associated with an increased risk of developing hype
Comparative real-world safety profiles of selective β1-adrenergic receptor blockers: A multi-database pharmacovigilance disproportionality study
Medicine (Baltimore). 2026 Sep 25;105(39):e50763. doi: 10.1097/MD.0000000000050763.ABSTRACTSelective β1-blockers are fundamental in managing hypertension, coronary artery disease, and heart failure. Yet, despite their widespread use, practical guidance on safe and individualized prescribing remains
Association between controlling nutritional status score and left ventricular hypertrophy in adults: A single-center retrospective cross-sectional study
Medicine (Baltimore). 2026 Sep 25;105(39):e50792. doi: 10.1097/MD.0000000000050792.ABSTRACTLeft ventricular hypertrophy (LVH) is an important marker of cardiovascular risk, while malnutrition is common among adults. The Controlling Nutritional Status (CONUT) score is an objective tool for nutritiona
Quantitative evaluation of the effect of hyperlipidemia on carotid artery stiffness in patients with type 2 diabetes mellitus using shear wave elastography
Medicine (Baltimore). 2026 Sep 25;105(39):e50829. doi: 10.1097/MD.0000000000050829.ABSTRACTType 2 diabetes mellitus (T2DM) is a major risk factor for atherosclerotic cardiovascular disease (CVD), and hyperlipidemia (HLD) frequently coexists. Shear wave elastography (SWE) quantifies carotid stiffness
Evolution and paradigms in ion channel and cardiac remodeling: A bibliometric analysis (1979-2024)
Medicine (Baltimore). 2026 Sep 25;105(39):e50846. doi: 10.1097/MD.0000000000050846.ABSTRACTOBJECTIVE: This study aims to conduct a bibliometric analysis of the literature on the role of ion channels in cardiac remodeling.METHODS: Articles on ion channels and cardiac remodeling from 1979 to 2024 were
Clinical efficacy of integrated traditional Chinese and Western medicine in patients with coronary artery disease
Medicine (Baltimore). 2026 Sep 25;105(39):e50810. doi: 10.1097/MD.0000000000050810.ABSTRACTCoronary artery disease (CAD) remains a major cause of morbidity and mortality worldwide. Although guideline-directed Western medical therapy improves cardiovascular outcomes, residual symptoms remain common.
Post-marketing safety of ensifentrine in COPD: A retrospective pharmacovigilance study using disproportionality analysis of FAERS/AEMS reports
Medicine (Baltimore). 2026 Sep 25;105(39):e50743. doi: 10.1097/MD.0000000000050743.ABSTRACTEnsifentrine is a newly approved inhaled dual phosphodiesterase 3 and 4 inhibitor for the maintenance treatment of chronic obstructive pulmonary disease. Because post-marketing safety experience is still limit
Neutrophil percentage-to-albumin ratio and all-cause mortality in cancer survivors with cardiovascular disease: Evidence from NHANES 1999-2018
Medicine (Baltimore). 2026 Sep 25;105(39):e50768. doi: 10.1097/MD.0000000000050768.ABSTRACTNeutrophil percentage-to-albumin ratio (NPAR) reflects both systemic inflammation and nutritional status, 2 factors closely linked to cancer progression and cardiovascular disease (CVD). While NPAR has been as
The Impact of Polycyclic Aromatic Hydrocarbons Exposure from Seasonal Biomass Burning on Oxidative Stress and Genotoxicity Biomarkers in Patients with Diabetes and Hypertension in Chiang Mai, Thailand
Toxics. 2026 Aug 29;14(9):771. doi: 10.3390/toxics14090771.ABSTRACTPolycyclic aromatic hydrocarbons (PAHs) are produced primarily by incomplete combustion of organic materials, including biomass burning, vehicle exhaust, and forest fires. Exposure to PAHs can induce reactive oxygen species (ROS) and
Heavy Metal Contamination in Commercial Coffee Products in Saudi Arabia: Prevalence, Carcinogenic and Non-Carcinogenic Risk Assessment, and Implications for Diabetes and Cardiovascular Disease
Toxics. 2026 Aug 26;14(9):761. doi: 10.3390/toxics14090761.ABSTRACTCoffee is deeply embedded in Saudi culture and is among the most consumed beverages worldwide. However, contamination by toxic heavy metals may represent an underrecognized public health concern, particularly in regions already burde
Real-World Utilization of the Novavax Adjuvanted Recombinant Protein COVID-19 Vaccine in France During the 2022-2024 Period
Vaccines (Basel). 2026 Sep 9;14(9):790. doi: 10.3390/vaccines14090790.ABSTRACTBACKGROUND/OBJECTIVES: The Novavax COVID-19 vaccine (Nuvaxovid™) was authorized in France in December 2021, assisting in ending the global pandemic and providing an alternative to other COVID-19 vaccines. Understanding Nuv
Dual Antigen Display on an AP205 VLP Platform Elicits Potent and Durable Neutralization of EBV Infection in B Cells and Epithelial Cells In Vitro
Vaccines (Basel). 2026 Aug 25;14(9):735. doi: 10.3390/vaccines14090735.ABSTRACTBACKGROUND/OBJECTIVES: Epstein-Barr virus (EBV) is a ubiquitous pathogen responsible for significant malignancies and autoimmune diseases, yet no prophylactic vaccine is available. The viral entry glycoproteins gL/gH and
Celastrol Attenuates Doxorubicin-Induced Heart Failure by Preserving Mitochondrial Integrity and Suppressing Oxidative Stress and Is Accompanied by Changes in Gut Microbiota
Pharmaceuticals (Basel). 2026 Sep 20;19(9):1494. doi: 10.3390/ph19091494.ABSTRACTBackground/Objectives: Doxorubicin (DOX) is an effective chemotherapeutic agent whose clinical use is limited by dose-dependent cardiotoxicity that may progress to irreversible heart failure. Celastrol (Cel), a bioactiv
Effects of Sarpogrelate Hydrochloride in Combination with Aspirin on Blood Viscosity and Hemorheological Parameters in Patients with Peripheral and Coronary Artery Disease: A Randomized Controlled Trial
Pharmaceuticals (Basel). 2026 Sep 7;19(9):1410. doi: 10.3390/ph19091410.ABSTRACTBackground/Objectives: Hemorheological abnormalities, including increased blood viscosity and impaired red blood cell (RBC) deformability, contribute to poor vascular outcomes in patients with atherosclerotic diseases. A
Natural Small Molecules Targeting Mitochondrial Quality Control for the Treatment of Metabolic Diseases: Mechanisms, Novel Formulations, and Translational Perspectives
Pharmaceuticals (Basel). 2026 Sep 5;19(9):1402. doi: 10.3390/ph19091402.ABSTRACTMetabolic diseases are jointly driven by insulin resistance, chronic inflammation, lipotoxicity, and disrupted organelle homeostasis arising from sustained nutrient overload. These disorders substantially increase the ri
Extraction, Phytochemical Profiling, and Computational Evaluation of Corymbia citriodora Essential Oil as a COX-2 Inhibitor: Steam vs. Microwave-Assisted Distillation, GC-MS/MS, Docking, DFT, and MD Simulations
Pharmaceuticals (Basel). 2026 Sep 1;19(9):1382. doi: 10.3390/ph19091382.ABSTRACTBackground/Objectives: Chronic inflammation sustained by cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) underlies many human diseases, while the cardiovascular liabilities of coxibs have renewed inte